HealthSouth Corp. (HLS) Shares Sold by Rice Hall James & Associates LLC
Rice Hall James & Associates LLC decreased its stake in shares of HealthSouth Corp. (NYSE:HLS) by 1.1% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 434,318 shares of the company’s stock after selling 4,762 shares during the period. Rice Hall James & Associates LLC owned about 0.48% of HealthSouth Corp. worth $16,860,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in HLS. State Street Corp boosted its position in shares of HealthSouth Corp. by 3.4% in the first quarter. State Street Corp now owns 1,880,351 shares of the company’s stock valued at $70,753,000 after buying an additional 61,337 shares in the last quarter. BlackRock Inc. boosted its position in shares of HealthSouth Corp. by 95.0% in the first quarter. BlackRock Inc. now owns 7,768 shares of the company’s stock valued at $292,000 after buying an additional 3,785 shares in the last quarter. Bayesian Capital Management LP bought a new position in shares of HealthSouth Corp. during the first quarter valued at about $259,000. Envestnet Asset Management Inc. boosted its position in shares of HealthSouth Corp. by 21.4% in the first quarter. Envestnet Asset Management Inc. now owns 38,222 shares of the company’s stock valued at $1,438,000 after buying an additional 6,738 shares in the last quarter. Finally, Cumberland Partners Ltd boosted its position in shares of HealthSouth Corp. by 178.5% in the second quarter. Cumberland Partners Ltd now owns 559,025 shares of the company’s stock valued at $21,702,000 after buying an additional 358,325 shares in the last quarter. Institutional investors own 94.94% of the company’s stock.
HealthSouth Corp. (NYSE:HLS) traded down 0.67% on Monday, hitting $40.30. 486,661 shares of the stock traded hands. HealthSouth Corp. has a 12 month low of $30.26 and a 12 month high of $43.38. The firm has a 50-day moving average price of $40.73 and a 200-day moving average price of $39.68. The company has a market capitalization of $3.62 billion, a PE ratio of 17.69 and a beta of 1.02.
HealthSouth Corp. (NYSE:HLS) last posted its earnings results on Thursday, July 28th. The company reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.60 by $0.09. The business had revenue of $920.70 million for the quarter, compared to the consensus estimate of $906.67 million. HealthSouth Corp. had a net margin of 6.26% and a return on equity of 28.99%. The company’s revenue for the quarter was up 20.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.47 EPS. Analysts forecast that HealthSouth Corp. will post $2.52 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Monday, October 3rd will be given a dividend of $0.24 per share. This is an increase from HealthSouth Corp.’s previous quarterly dividend of $0.23. The ex-dividend date is Thursday, September 29th. This represents a $0.96 dividend on an annualized basis and a yield of 2.38%. HealthSouth Corp.’s dividend payout ratio (DPR) is 42.29%.
Several equities analysts recently issued reports on HLS shares. Wells Fargo & Co. reiterated a “buy” rating on shares of HealthSouth Corp. in a research report on Sunday, September 11th. Zacks Investment Research lowered shares of HealthSouth Corp. from a “buy” rating to a “hold” rating in a research note on Friday, August 5th. Barclays PLC lowered shares of HealthSouth Corp. from an “equal weight” rating to an “underweight” rating and dropped their price objective for the stock from $45.00 to $42.00 in a research note on Monday, June 27th. They noted that the move was a valuation call. SunTrust Banks Inc. set a $54.00 price objective on shares of HealthSouth Corp. and gave the stock a “buy” rating in a research note on Monday, August 1st. Finally, JMP Securities reissued a “buy” rating on shares of HealthSouth Corp. in a research note on Sunday, September 4th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $46.00.
In other HealthSouth Corp. news, COO Mark J. Tarr sold 20,000 shares of the firm’s stock in a transaction dated Tuesday, August 2nd. The shares were sold at an average price of $41.85, for a total transaction of $837,000.00. Following the transaction, the chief operating officer now owns 252,519 shares of the company’s stock, valued at approximately $10,567,920.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 5.00% of the company’s stock.
HealthSouth Corp. Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.
Receive News & Stock Ratings for HealthSouth Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp. and related stocks with our FREE daily email newsletter.